Outcomes of atherosclerotic renal artery stenosis managed without revascularization

Mayo Clinic Proceedings

Volumn 75, Issue 5, 2000, Pages 437-444

  Chábová, Vera ^a,b   Schirger, Alexander ^a,b,c   Stanson, Anthony W ^b,c   McKusick, Michael A ^a,b   Textor, Stephen C ^c  

^a Division of Hematology and Internal Medicine   (United States)

^b Department of Diagnostic Radiology ^*  (United States)

^c MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHRECTOMY; REVASCULARIZATION;

EID: 0034065155     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-6196(11)64210-9     Document Type: Article

References (38)

1. Novick AC, Pohl MA, Schreiber M, Gifford RW Jr, Vidt DG. Revascularization for preservation of renal function in patients with atherosclerotic renovascular disease. J Ural. 1983; 129:907-912.
2. Olin JW, Melia M, Young JR, Graor RA, Risius B. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med. 1990;88(1N):46N-51N.
3. Hansen KJ. Prevalence of ischémie nephropathy in the atherosclerotic population. Am J Kidney Dis. 1994;24:615-621.
4. Shanley PF. The pathology of chronic renal ischemia. Semin Nephrol. 1996; 16:21-32.
5. Textor SC, Smith-Powell L. Pathophysiology of renal failure in ischémie renal disease. In: Novick AC, Scoble J, Hamilton G, eds. Renal Vascular Disease. London, England: WB Saunders Co; 1996:289-302.
6. Textor SC. Revascularization in atherosclerotic renal artery disease. Kidney Int. 1998:53:799-811.
7. Hallett JW Jr, Textor SC, Kos PB, et al. Advanced renovascular hypertension and renal insufficiency: trends in medical comorbidity and surgical approach from 1970 to 1993. J Vase Surg. 1995: 21:750-759.
8. Webster J, Marshall F. Abdalla M, et al, Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Randomised comparsion of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. J Hum Hypertens. 1998; 12:329-335.
9. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 [published correction appears in BMJ. 1999;318:29]. BMJ. 1998;317:703-713.
10. Peterson JC, Adler S, Burkart JM, et al. Blood pressure control, proteinuria, and the progression of renal disease: the Modification of Diet in Renal Disease Study. Ann Intern Med. 1995; 123:754-762.
11. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl .1 Med. 1987 ;316:1429-1435.
12. Zierler RE, Bergelin RO, Davidson RC, Cantwell-Gab K, Polissar NL, Strandness DE Jr. A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. Am J Hypertens. 1996;9:1055-1061.
13. Schreiber MJ Jr, Pohl MA, Novick AC. Preserving renal function by revascularization. Annu Rev Med. 1990;41:423-429.
14. Caps MT, Zierler RE, Polissar NL, et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int. 1998;53:735742.
15. Wilkinson L, Hill M, Welna JP, Birkenbeuel GK. Systat for Windows: Statistics. Evanston, 111: Systat Inc; 1992:1-750.
16. JNC-VI: The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Rockville, Md: National Institutes of Health; 1997. NIH publication 98-4080.
17. Krijnen P, van Jaarsveld BC, Steyerberg EW, Man in't Veld AJ, Schalekamp MA, Habbema JD. A clinical prediction rule for renal artery stenosis. Ann Intern Med. 1998;!29:705-711.
18. Dorros G, Jaff M, Mathiak L, et al. Four-year follow-up of PalmazSchatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 1998;98:642-647.
19. Bonelli FS, McKusick MA, Textor SC, et al. Renal artery angioplasty: technical results and clinical outcome in 320 patients. Mayo Clin Proc. 1995;70:1041 -1052.
20. Schneider EL, Guralnik JM. The aging of America: impact on health care costs. JAMA. 1990;263:2335-2340.
21. Cambria RP, Brewster DC, L'Italien GJ, et al. Renal artery reconstruction for the preservation of renal function. J Vase Surg. 1996; 24:371-380.
22. Conlon PJ, Athirakul K, Kovalik E, et al. Long term follow up of asymptomatic renal vascular disease [abstract]. J Am Soc Nephrol. 1996;7:1384. Abstract A0692.
23. Plouin PF, Chatellier G, Darne B, Raynaud A, Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Hypertension. 1998;31:823-829.
24. Scoble JE, Hamilton G. Atherosclerotic renovascular disease. BMJ. 1990:300:1670-1671.
25. Jacobson HR. Ischémie renal disease: an overlooked clinical entity? Kidney Int. 1988;34:729-743.
26. Greco B A, Breyer JA. The natural history of renal artery stenosis: who should be evaluated for suspected ischémie nephropathy? Semin Nephrol. 1996; 16:2-11.
27. Tollefson DF, Ernst CB. Natural history of atherosclerotic renal artery stenosis associated with aortic disease. J Vase Surg. 1991 ; 14: 327-331.
28. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am. 1984:11:383-392.
29. Caps MT, Perissinotto C, Zierler RE, et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation. 1998:98:2866-2872.
30. Crowley JJ, Conlon PJ, Santos RM, et al. Incidence and progression of renal artery atherosclerosis in patients undergoing cardiac catheterization [abstract]. Circulation. 1996;94(suppl I):I-299. Abstract 1744.
31. Dean RH, Kieffer RW, Smith BM, et al. Renovascular hypertension: anatomic and renal function changes during drug therapy. Arch Surg. 1981:116:1408-1415.
32. Conlon PJ, Athirakul K, Kovalik E, et al. Survival in renal vascular disease. J Am Soc Nephrol. 1998:9:252-256.
33. Welch HG, Albertsen PC, Nease RF, Bubolz TA, Wasson JH. Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med. 1996:124:577-584.
34. White CJ. Open renal arteries are better than closed renal arteries [editorial]. Cathet Cardiovasc Diagn. 1998;45:9-10.
35. Jaff MR, Olin JW. Atherosclerotic stenosis of the renal arteries: indications for intervention. Tex Heart Inst J. 1998;25:34-39.
36. Tullis MJ, Zierler RE, Glickerman DJ, Bergelin RO, CantwellGab K, Strandness DE Jr. Results of percutaneous transluminal angioplasty for atherosclerotic renal artery stenosis: a followup study with duplex ultrasonography. J Vase Surg. 1997:25:4654.
37. Case records of the Massachusetts General Hospital: weekly clinicopathological exercises. N Engl J Med. 1998:339:329-337. Case 24-1998.
38. Connolly JO, Higgins RM, Walters HL, et al. Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease. QJM. 1994:87:413-421.